Liver microsomal cytochrome P450 3A-dependent drug oxidation activities in individual dogs

References

• Court MH. 2013. Canine cytochrome P-450 pharmacogenetics. Vet Clin North Am Small Anim Pract. 43(5):1027–1038.
   PubMed Web of Science ®Google Scholar
• Hay Kraus BL, Greenblatt DJ, Venkatakrishnan K, Court MH. 2000. Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences. Xenobiotica. 30(6):575–588.
   PubMed Web of Science ®Google Scholar
• Heikkinen AT, Friedlein A, Lamerz J, Jakob P, Cutler P, Fowler S, Williamson T, Tolando R, Lave T, Parrott N. 2012. Mass spectrometry-based quantification of CYP enzymes to establish in vitro/in vivo scaling factors for intestinal and hepatic metabolism in beagle dog. Pharm Res. 29(7):1832–1842.
   PubMed Web of Science ®Google Scholar
• Heikkinen AT, Friedlein A, Matondo M, Hatley OJ, Petsalo A, Juvonen R, Galetin A, Rostami-Hodjegan A, Aebersold R, Lamerz J, et al. 2015. Quantitative ADME proteomics – CYP and UGT enzymes in the Beagle dog liver and intestine. Pharm Res. 32(1):74–90.
   PubMed Web of Science ®Google Scholar
• Locuson CW, Ethell BT, Voice M, Lee D, Feenstra KL. 2009. Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase. Drug Metab Dispos. 37(3):457–461.
   PubMed Web of Science ®Google Scholar
• Martinez SE, Shi J, Zhu HJ, Perez Jimenez TE, Zhu Z, Court MH. 2019. Absolute quantitation of drug-metabolizing cytochrome p450 enzymes and accessory proteins in dog liver microsomes using label-free standard-free analysis reveals interbreed variability. Drug Metab Dispos. 47(11):1314–1324.
   PubMed Web of Science ®Google Scholar
• Mealey KL, Jabbes M, Spencer E, Akey JM. 2008. Differential expression of CYP3A12 and CYP3A26 mRNAs in canine liver and intestine. Xenobiotica. 38(10):1305–1312.
   PubMed Web of Science ®Google Scholar
• Mealey KL, Martinez SE, Villarino NF, Court MH. 2019. Personalized medicine: going to the dogs? Hum Genet. 138(5):467–481.
   PubMed Web of Science ®Google Scholar
• Mise M, Yadera S, Matsuda M, Hashizume T, Matsumoto S, Terauchi Y, Fujii T. 2004. Polymorphic expression of CYP1A2 leading to interindividual variability in metabolism of a novel benzodiazepine receptor partial inverse agonist in dogs. Drug Metab Dispos. 32(2):240–245.
   PubMed Web of Science ®Google Scholar
• Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Pedersen NC. 2004. Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage. Proc Natl Acad Sci U S A. 101(32):11725–11730.
   PubMed Web of Science ®Google Scholar
• Paulson SK, Engel L, Reitz B, Bolten S, Burton EG, Maziasz TJ, Yan B, Schoenhard GL. 1999. Evidence for polymorphism in the canine metabolism of the cyclooxygenase 2 inhibitor, celecoxib. Drug Metab Dispos. 27(10):1133–1142.
   PubMed Web of Science ®Google Scholar
• Shida S, Yamazaki H. 2016. Human plasma concentrations of five cytochrome P450 probes extrapolated from pharmacokinetics in dogs and minipigs using physiologically based pharmacokinetic modeling. Xenobiotica. 46(9):759–764. eng.
   PubMed Web of Science ®Google Scholar
• Shimada T, Guengerich FP. 1989. Evidence for cytochrome P-450 NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. Proc Natl Acad Sci U S A. 86(2):462–465.
   PubMed Web of Science ®Google Scholar
• Shimada T, Mimura M, Inoue K, Nakamura S, Oda H, Ohmori S, Yamazaki H. 1997. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Arch Toxicol. 71(6):401–408. eng.
   PubMed Web of Science ®Google Scholar
• Tenmizu D, Endo Y, Noguchi K, Kamimura H. 2004. Identification of the novel canine CYP1A2 1117 C>T SNP causing protein deletion. Xenobiotica. 34(9):835–846.
   PubMed Web of Science ®Google Scholar
• Uno Y, Jikuya S, Noda Y, Murayama N, Yamazaki H. 2023a. A comprehensive investigation of dog cytochrome P450 3A (CYP3A) reveals a functional role of newly identified CYP3A98 in small intestine. Drug Metab Dispos. 51(1):38–45.
   PubMed Web of Science ®Google Scholar
• Uno Y, Morikuni S, Shiraishi M, Asano A, Murayama N, Yamazaki H. 2023b. Novel cytochrome P450 2C94 functionally metabolizes diclofenac and omeprazole in dogs. Drug Metab Dispos. 51 (5):637–644.
   PubMed Web of Science ®Google Scholar
• Uno Y, Murayama N, Ijiri M, Kawaguchi H, Yamato O, Shiraishi M, Asano A, Teraoka H, Mizukawa H, Nakayama SMM, et al. 2022a. Cytochrome P450 2J genes are expressed in dogs, cats, and pigs, and encode functional drug-metabolizing enzymes. Drug Metab Dispos. 50(11):1434–1441.
   PubMed Web of Science ®Google Scholar
• Uno Y, Noda Y, Murayama N, Tsukiyama-Kohara K, Yamazaki H. 2023c. Novel cytochrome P450 1 (CYP1) genes in tree shrews are expressed and encode functional drug-metabolizing enzymes. Comp Biochem Physiol C Toxicol Pharmacol. 265:109534.
   PubMed Web of Science ®Google Scholar
• Uno Y, Shimizu M, Ogawa Y, Makiguchi M, Kawaguchi H, Yamato O, Ishizuka M, Yamazaki H. 2022b. Molecular and functional characterization of flavin-containing monooxygenases in pigs, dogs, and cats. Biochem Pharmacol. 202:115125.
   PubMed Web of Science ®Google Scholar
• Uno Y, Uehara S, Yamazaki H. 2022c. Drug-oxidizing and conjugating non-cytochrome P450 (non-P450) enzymes in cynomolgus monkeys and common marmosets as preclinical models for humans. Biochem Pharmacol. 197:114887.
   PubMed Web of Science ®Google Scholar
• Uno Y, Ushirozako G, Uehara S, Murayama N, Fujiki Y, Kawaguchi H, Tsukiyama-Kohara K, Yamazaki H. 2022d. Newly identified tree shrew cytochrome P450 2B6 (CYP2B6) and pig CYP2B6b are functional drug-metabolising enzymes. Xenobiotica. 52(7):687–696.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Schwab M. 2013. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 138(1):103–141.
   PubMed Web of Science ®Google Scholar